SARS-CoV-2 and myocardial injury: Few answers, many questions.Cleve Clin J Med. 2020 08 31; 87(9):521-525.CC
Abstract
Acute cardiac injury, defined as an elevated high-sensitivity troponin I or troponin T upon admission or during hospitalization, is common in patients with COVID-19, occurring in 10% to 35% of patients depending on the assay used and the population studied. Even though the mechanisms of SARS-CoV-2 myocardial injury are not well defined, type 1 myocardial infarction and fulminant myocarditis are rare. Often, acute cardiac injury occurs in patients with elevated inflammatory markers, and both are associated with worse outcomes. However, the extent to which treatments should differ for patients with acute cardiac injury, heightened systemic inflammation, or both, is unknown.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32371557
Citation
Cremer, Paul C.. "SARS-CoV-2 and Myocardial Injury: Few Answers, Many Questions." Cleveland Clinic Journal of Medicine, vol. 87, no. 9, 2020, pp. 521-525.
Cremer PC. SARS-CoV-2 and myocardial injury: Few answers, many questions. Cleve Clin J Med. 2020;87(9):521-525.
Cremer, P. C. (2020). SARS-CoV-2 and myocardial injury: Few answers, many questions. Cleveland Clinic Journal of Medicine, 87(9), 521-525. https://doi.org/10.3949/ccjm.87a.ccc001
Cremer PC. SARS-CoV-2 and Myocardial Injury: Few Answers, Many Questions. Cleve Clin J Med. 2020 08 31;87(9):521-525. PubMed PMID: 32371557.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - SARS-CoV-2 and myocardial injury: Few answers, many questions.
A1 - Cremer,Paul C,
Y1 - 2020/08/31/
PY - 2020/5/7/pubmed
PY - 2020/9/10/medline
PY - 2020/5/7/entrez
SP - 521
EP - 525
JF - Cleveland Clinic journal of medicine
JO - Cleve Clin J Med
VL - 87
IS - 9
N2 - Acute cardiac injury, defined as an elevated high-sensitivity troponin I or troponin T upon admission or during hospitalization, is common in patients with COVID-19, occurring in 10% to 35% of patients depending on the assay used and the population studied. Even though the mechanisms of SARS-CoV-2 myocardial injury are not well defined, type 1 myocardial infarction and fulminant myocarditis are rare. Often, acute cardiac injury occurs in patients with elevated inflammatory markers, and both are associated with worse outcomes. However, the extent to which treatments should differ for patients with acute cardiac injury, heightened systemic inflammation, or both, is unknown.
SN - 1939-2869
UR - https://www.unboundmedicine.com/medline/citation/32371557/SARS_CoV_2_and_myocardial_injury:_Few_answers_many_questions_
L2 - https://www.ccjm.org/cgi/pmidlookup?view=long&pmid=32371557
DB - PRIME
DP - Unbound Medicine
ER -